After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Idexx Laboratories, Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. The current market capitalization of Idexx Laboratories, Inc is $51.27B. A total of 0.52 million shares were traded on the day, compared to an average of 585.90K shares.
In the most recent transaction, SZOSTAK M ANNE sold 2,187 shares of IDXX for 647.33 per share on Aug 22 ’25. After the transaction, the Director now owns 262 company shares. In a previous transaction on Aug 22 ’25, MARGARET ANNE SZOSTAK bought 2,187 shares at 647.33 per share.
Among the insiders who sold shares, Erickson Michael G disposed of 406 shares on Aug 12 ’25 at a per-share price of $649.96. This resulted in the Executive Vice President holding 11,287 shares of IDXX after the transaction. In another insider transaction, Hunt Nimrata sold 1,200 shares at $656.53 per share on Aug 11 ’25. Company shares held by the Executive Vice President now total 16,807.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, IDXX has a high of $688.12 and a low of $356.14.
As of this writing, IDXX has an earnings estimate of $3.13 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of $3.27 per share and a lower estimate of $2.99. The company reported an EPS of $2.8 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IDXX’s latest balance sheet shows that the firm has $144.45M in Cash & Short Term Investments as of fiscal 2021. There were $1.03B in debt and $763.58M in liabilities at the time. Its Book Value Per Share was $18.20, while its Total Shareholder’s Equity was $689.99M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IDXX is Buy with a score of 4.08.
